Holloway Jean F, Senior Vice President and General Counsel, has demonstrated a clear selling bias in their trading activity involving Artivion, Inc. (AORT), the only company in their transaction history. Over 45 reported trades, Holloway has sold $5.16 million worth of shares while purchasing $1.80 million, with all 17 most recent transactions being sales. The selling activity has been consistent and substantial, including multiple six-figure dispositions such as a $340,556 sale on March 4, 2026, a $288,816.98 sale on November 17, 2025, and a $730,111.73 sale on August 12, 2025. The transactions often occur in clusters, with multiple sales executed within short timeframes—such as three sales totaling $568,736.99 across March 2–4, 2026, and four sales worth $1.04 million between November 10–17, 2025.
The pattern suggests an ongoing reduction in Holloway’s position, with no recent purchases offsetting the sales. Many of the transactions are marked as open-market sales ("S"), while others involve the disposition of shares acquired through derivative securities like options exercises ("M"). For example, on August 12, 2025, Holloway sold $274,497.86 in open-market shares alongside $730,111.73 in additional sales, while also exercising options worth $445,424. The absence of any buys in the recent filings, combined with the frequency and scale of the sales, indicates a sustained divestment from AORT. The transactions do not appear tied to a single event but rather reflect a prolonged trend of reducing exposure to the company’s stock.
AI-assisted summary